Article
Small molecule activation of the tumor suppressor kinase LKB1
2024-12-20
Abstract excerpt
The ability to identify and target oncogenic signals has transformed clinical oncology. Drug development for targeted therapies has historically focused on the inhibition of oncogenic kinases and GTPases. However, many cancer patients do not benefit from targeted approaches because their tumors lack targetable mutations. Therapeutic augmentation of tumor suppressive signaling could be a viable alternative but pose...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 574d9352-6ebd-5b02-8fdc-c69f8b56629c
- DOI
- 10.1101/2024.12.17.628051
